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The Preininger-alkaloid, dehydro-normacrostomine (2b, Scheme 1) was 
synthesized starting from rac. a-acetyl-3,4-dimethoxybenzylcyanide (3) 
(Scheme 2). The key intermediate 4-acetyl-6,7-dimethoxy-l-(3,4-methylene-
dioxybenzyl)isoquinoline (11) is converted via a Mannich base to the nitrile 
17 (Scheme 7) which in turn is cyclized to the Preininger-?Sks\o\d (2b) by 
careful hydrogenation. - Reduction of 2b with a modified Iwakuma-reagenu 
followed by N-formylation and subsequent LiAlH4-reduction produced (/?)-
(+)-macrostomine (enantiomer of 1) in 72 % optical purity. 
Synthese des P/Wm/iger-Alkaloids und dessen enantioselektive Reduk-
tion zu Macrostomin 
Das Preininger-Alkaloid (Dehydro-normacrostomin, 2b, Scheme 1) wurde 
ausgehend von rac. a-Acetyl-3,4-dimethoxybenzylcyanid (3) über die 
Schlüsselverbindung 4-Acetyl-6,7-dimethoxy-1 -(3,4-methylendioxyben-
zyl)isochinolin (11) synthetisiert. Die Umsetzung von 11 über eine Mannich-
Base zum Nitril 17 (Scheme 7) und dessen schonende Hydrierung führten 
zum Preininger-Alkäloid (2b). - Die Reduktion von 2b mit einem modifi-
zierten Iwokuma-Reagenz, N-Formylierung und Alanat-Reduktion lieferten 
(/?M+)-Macrostomin (Enantiomer von 1) in 72 proz. optischer Reinheit 
In 1974 Santavf, Preininger et al. l ) reported upon isola-
tion and structure elucidation of a benzylisoquinoline alka-
loid from papaver macrostomum, papaveraceae, named 
macrostomine (1). For this alkaloid 5-configuration at C-2 
of the pyrrolidine-increment was established by chiroptical 
comparison with (S)-(-)-nicotine and (5)-(-)-brevicoline. 
Traces of a new alkaloid, dehydro-normacrostomine (2a) 
were isolated from papaver macrostomum by the same 
group in 1976 2 \ In commemoration of the late V. Prein-
inger we have named dehydro-normacrostomine "Prein-
inger-alkaloid\ Here we describe the synthesis of this alka-
loid and a marginal correction of its structural formula (2b 
instead of 2a, see below). 
(wrong, not an enambie) Prdninger-alkaloid 
Scheme 1 
Rac. a-acetyl-3,4-dimethoxybenzylcyanide3) (3) was con-
verted to 4 which was reduced by I^H^ to the ß-phenyl-
ethylamine 5. Aminolysis of methyl (3,4-methy lenedioxy-
phenyl)acetate (6) with amine 5 afforded the amide 7 which 
was cylcized to 8 according to Bischler-Napieralski 4 \ 
NaBHj led to the tetrahydroisoquinoline 9a. We were not 
bothered about stereoisomers because the centers of chir-
ality at C- l and C-4 were abolished in the following steps. 
This hydrogenation seems to be a detour because a (dehydrogenated) 
isoquinoline systems was aspired. On account of the sensitivity of 1-
benzyl-3,4-dihydroisoquinoline bases, however, which are easily converted 
to l-benzoyl-3,4-dihydroisoquinolines by exposure to air 5 ) , we could not 
remove the dithioketal protecting group successfully. This step, however, 
would have been mandatory in order to avoid disturbances of the Pd/C-
catalyzed dehydrogenation by the sulfur-increment. 
Various attempts for cleaving the dithioketal in 9a 
failed 6 ) . Meerwein's reagent 7 ) , e.g., led to /V-ethylation 
(9b) but did not attack the dithioketal. 
According to Fujita 8 ) even those S-protecting groups 
being resistant against T1(N03)3 can be removed by 
Hg(ClC>4)2. This reagent has smoothly liberated the ketone 
moiety of the ß-aminoketone 10. Dehydrogenation of 10 led 
to the 4-acetyl-l-benzylisoquinoline 11 in 82 % yield 
besides 6.5 % of 11a. 
A rationalization for the formation of the by-product 11a 
is given in Scheme 4. 
Alternatively the dithioketal moiety in amide 7 was 
removed by Hg(C104)2 producing compound 12 which was 
cyclized to the 3,4-dihydroisoquinoline 13, but direct dehy-
drogenation of 13 afforded the 4-acetyl-l-benzylisoqui-
noline 11 in 18 - 22 % yield only. 
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Our efforts to build up the pyrroline moiety of Preininger-
alkaloid adopting synthetic routes elaborated by Leete 9), 
Knott10), or Burckhalter n ) and nicely working in the prep-
aration of 2-(hetero)aryl-pyrrolines 1 2 ) failed: Böhme salt 
(A^^V-dimethyl-methyleneammonium chloride) 1 3 ) or the 
corresponding acetate 1 4 ) did not react with 11 at room 
temp., whilst at 80°C (chloride form) or 40°C (acetate 
form) the CH2-group was attacked leading to the aza-
Mannich base 14 (Scheme 6). 
We had been aware of this possibility but 1-(3,4-methylenedioxybenzyl)-
6,7-dimethoxyisoquinoline 1 5 ) did not react under these conditions. Prob-
ably the 4-acetyl increment in 11 increases the C-H-acidity of the C H 2 -




group. Therefore, the following steps were performed analogously to those 
described for our modified synthesis of the nicotiana alkaloid 
myosmine16). 




Our key compound 11 was silylated according to Sim-
chenxl) affording the enol derivative 15, which was treated 
with N^V-dimethyl-methyleneammonium iodide (Eschen-
moser salt) followed by hydrolysis with dil. HCl, producing 
the Mannich base 16; both steps are analogous to those 
reported by Danishefsky 1 8 ) . 16-HC1 is converted by CN" to 
the ß-cyanoketone 17. This step does not work with 16-
base, because it decomposes easily by a retro-Afdwmc/j-re-
action. Careful hydrogenation (cf. Scheme 7) led to 2b, the 
Preininger-aXkaloid. 
If the enol derivative 15 is allowed to react with Böhme-
Eschenmoser salt (iodide form) for 12 h (instead of 90 min 
only) and the crude mixture is treated with KCN followed 
by hydrogenation as described above, the C-9-methylated 
Preininger-eAkdloid 18 is obtained. 
We assume that also in this case the CH2-group had reacted with the 
N,N-dimethyl-methyleneammonium salt to an aza-Mannich base. Loss of 
dimethylamine from the pertinent enamine tautomere to the C-9-methylene 
increment und subsequent hydrogenation then affords compound 18 (cf. 
Scheme 8). 
As mentioned in the introductory remarks formula 2a had 
been attributed to dehydro-normacrostomine 2 ) , whilst on 
the other side compound 2b fits all the analytical data cited 
by Santavy, Preininger et al. 2 )* ). These authors have de-
duced the enamine-structure from H/D-exchange experi-
ments with "deuterioethanor, giving rise of an (M+l)-peak 
in the mass spectrum and "to a smaller extent" of (M+2). 
Obviously the quantity available (7 mg 2 )) of this alkaloid 
was too small for ^-NMR-experiments at that time. -
There are no experimental data for that H/D-exchange ex-
periment. We used CD3OD and found only 10 % exchange. 
Because a D+-catalyzed reaction is conceivable (traces of 
CD3-COOD in the deuterioethanol ?) we have stirred 2b 
with CD3-COOD at 30°C for 3 h. The result (up to 5 H 
exchanged) is shown in fig. 1. 
Obviously not only the aza-allyl system but also the 
benzylic CH2-group is prone to H/D-exchange. - The *H-
NMR-spectrum of 2b is shown in fig. 2. 
We have reported on the enantioselective hydrosilylation 
of the Preininger-dükdloid (2b) affording (5)-(-)-macro-
stomine (1) with 33 % ee 1 9 ) . 
Reduction of 2b with NaBHt/N-benzyloxycarbonyl-L-
proline (cf. Iwakuma 2 0 )) and subsequent iV-formylation by 
CH3-CO-O-CO-H afforded rotamers of (/?)-(+HV-formyl-
normacrostomine (19) which were reduced to (/?)-(+)-mac-
1: Enamines, 2 nd ed., p. 460, GA. Cook ed., M. Dekker, Inc., New York ... 
rostomine (enantiomer of 1) by UAIH4 in 90 % chemical 
yield and 72 % optical purity (calculated by adopting Prein-
inger's [<X]D 5 = 51° (+/- 3°), c = 0.9, CHC13, for natural 
macrostomine (1)) 2 ) . Because the reducing reagent for 2b 
can also be prepared with D-proline this method opens an 
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Fig. 1: H/D-exchange; Preininger-alkaloid (2b) 
0CH3 (C-7) 
H3CO. 
AO 8.6 7.4 6.8 5.9 4.6 4.2 4.0 
Fig. 2:400 MHz- 1 H-NMR-spectrum of Preininger-alkaloid (2b) 
20:R = H 
Scheme 8 
Moreover, 19 can be hydrolyzed to the pertinent normac-
rostomine 20. 
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Experimental Part 
General remarks: l i t . 1 6 ) ; A1 2 0 3 : activity II-III, Brockmann. - All temp, 
in °C . 
a-(3,4-Dimethoxyphenyl)<i-(2-methyl-13-dithiolan-2-yl)aceto (4) 
54.8 g (0.25 mole) a-acetyl-3,4-dimethoxybenzylcyanide (3) 3 ) , dis-
solved in 400 ml of absol. CH 2C1 2, 24.54 g (0.26 mole) 1,2-dimercap-
toethane and 20 ml BF3-etherate were stirred at room temp, for 16 h. After 
addition of water (100 ml) and alkalization with 5 % NaOH the mixture 
was extracted with CH 2C1 2. The org. layer was washed with water and 
dried (Na2S04). After evaporation the light yellow oil was purified by 
kugelrohr-distillation (210°, 0.05 mm Hg): colourless crystals, m.p. 82 - 83° 
(MeOH), 70.2 g (95 %). - C 1 4 H 1 7 N 0 2 S 2 (295.4) Calcd. C 56.4 H 5.70 N 
4.7 Found C 56.3 H 5.66 N 4.6. - UV (MeOH): \ max (log E) = 279 (3.50), 
236 nm (3.95). - IR (KBr): 2270 cm"1 ( C N ) . - J H-NMR: 5 (ppm) = 1.8 (s; 
3H, CH 3), 3.2 - 3.48 (m; 4H, S-CH2-CH2-S), 3.89 (s; 3H, OCH 3), 3.91 (s; 
3H, OCH 3), 4.2 (s; 1H, CH-CN) , 6.85 (d; J A B = 9 Hz, 1H, Ar-H-5), 7.5 (dd; 
J 1 / 2 = 9/1.5 Hz, 2H, Ar-H-6 and H-2). 
2-(3,4-Dimethoxyphenyl)-2-(2-methyl-lJ-dithiolan-2-yl)-ethylamine (5) 
500 ml B2H6-tetrahydrofuran complex (1 mole/1) were added drop by 
drop to 118 g (0.4 mole) of 4 in 350 ml of absol. THF at room temp, under 
N 2 . After 45 min reflux about 750 ml of THF were distilled off and EtOH 
(130 ml) was added drop by drop at 0°. After alkalization with aqueous 
N H 3 amine 5 is extracted with CHC13. After drying (Na2S04) and evapora-
tion the remaining oil is purified by kugelrohr-distillation (190°, 0.01 mm 
Hg): nearly colourless viscous oil, 116.2 g (97 %). 5-base was transformed 
to 5-HC1 by gaseous HCl in Et 20: colourless crystals, m.p. 233 - 234°. -
C M H ^ N O Ä - C I (335.9) Calcd. C 50.1 H 6.55 N 4.2 Found C 50.0 H 6.65 
N 4.0. - UV (MeOH): X max (log e) = 275 (3.72), 263 nm (3.71). - IR 
(KBr): 3200 cm' 1 (N-H+). - ! H-NMR: 8 (ppm) = 1.04 (s; 2H, NH 2 , H/D-ex-
change), 1.66 (s; 3H, CH 3), 2.84 - 3.6 (m; 3H, Ph-CH-CH2), 3.26 (s; 4H, 
S-CH2-CH2-S), 3.9 (s; 6H, OCH 3), 6.75 - 7.06 (m; 3H, Ar-H). 
N-[2-(3A-Dimethoxyphenyl)-2-(2-methyl-13-dithio^ 
(3,4-methylenedioxyphenyljacetamide (7) 
29.9 g (0.1 mole) amine 5 and 21.3 g (0.11 mole) methyl (3,4-methyle-
nedioxyphenyl)acetate (6) are heated together to 150° for 16 h. After cool-
ing 7 is dissolved in ethyl acetate and filtered. After evaporation, amide 7 
is purified by cc (A1 20 3; EtOAc) and kugelrohr-distillation (230 - 240°, 
0.01 mm Hg): colourless crystals, m.p. 108 - 109° (CH 3 CN), 42.9 (93 %). -
C 2 3 H 2 7 N 0 5 S 2 (461.6) Calcd. C 59.8 H 5.89 N 3.0 Found C 59.7 H 5.73 N 
3.1. - IR (KBr): 3310 (N-H); 1660 cm"1 (NC=0). - ! H-NMR: 8 (ppm) = 
1.61 (s; 3H, CH 3) 2.96 - 4.41 (m; 7H, Ph-CH-CH 2 and S-(CH2)2-S), 3.3 (s; 
2H, Ph-CH2), 3.84 (s; 3H, OCH 3), 3.92 (s; 3H, OCH 3), 5.1 - 5.41 (m; 1H, 
NH, H/D-exchange), 5.94 (s; 2H, 0-CH 2-0); 6.28 - 6.91 (m; 6H, Ar-H). 
6,7-Dimethoxy-4-(2-methyl-13-dithiolan-2-yl)-l-(3,4-methylendio 
benzyl)-3,4-dihydroisoquinoline-HCl (8) 
18.46 g (0.04 mole) amide 7 were dissolved in 50 ml of absol. CH 3 CN 
under N 2 .14 ml POCl 3 in 10 ml of absol. CH 3 CN were added drop by drop 
at 0*. The mixture was stirred at room temp, for 4 days, then the crystals 
were filtered. The filtrate is diluted with acetone (100 ml) and NaHC0 3 (10 
ml of a saturated solution) was added: the crystals so obtained were com-
bined with the crystals mentioned above and recrystallized from MeOH: 
colourless crystals, m.p. 241° (decomp.), 17.3 g (90 %). - C 2 3 H 2 6 N 0 4 S r C l 
(480.0) Calcd. C 57.5 H 5.45 N 2.9 Found C 57.3 H 5.45 N 3.0. - UV 
(MeOH): X max (log e) = 305 (sh, 3.78), 286 (4.01), 230 nm (4.43). - IR 
(KBr): 1670 cm"1 (C=N). - MS: m/z = 443 (M+*; base, 1 %), 325 (94), 324 
(62), 308 (6), 202 (10), 171 (3), 135 (11), 119 (100). 
6,7-Dimethoxy-4-(2-methyl-13-dithiolan-2-yl)-l-(3,4-methylenedioxy-
benzyl)-l 23,4-tetrahydroisoquinoline (9a) 
To 14.4 g (0.03 mole) 8-HC1, dissolved in 130 ml of absol. MeOH, were 
added under N 2 2.7 g (71.3 mmole) of NaBH 4 in portions at 0°. The 
mixture was stirred for 1 h at 0°. Then excess of NaBH 4 was destroyed by 
2N HCl, MeOH was distilled off in vacuo and the remaining mixture was 
extracted with CH 2C1 2. The org. phase is washed with saturated NaHC0 3-
solution and dried (Na2S04). Evaporation yielded 13 g of an amorphous 
powder (97 %). 9- picrate: m.p. 182 - 183* (EtOH). - C 2 3 H 2 7 N 0 4 S 2 (base) 
(445.6) Calcd. C 51.7 H 4.45 N 8.30 Found C 51.9 H 4.46 N 8.3. - UV 
(MeOH): X max (log e) = 285 (3.89), 225 nm (4.16). - IR (KBr): 3400 cm"1 
(broad, N-H). - ! H-NMR: 8 (ppm) = 1.85 (s; 3H, CH 3), 1.29 (s; 1H, NH, 
H/D-exchange), 2.65 - 4.39 (m; 6H, Ph-CH-CH 2 and NH-CH-CH^), 3.28 
(s; 4H, S-(CH2)2-S), 3.85 (s; 3H, OCH 3), 3.9 (s; 3H, OCH 3), 5.94 (s; 2H, 
0-CH 2-0), 6.65 - 6.92 (m; 4H, Ar-H), 7.35 (s; 1H, Ar-H). - MS: m/z = 444 
((M - H) + , 1 %), 326 (8), 325 (20), 310 (100), 192 (24), 191 (25), 190 (65), 
135(16), 119(98). 
6,7-Dimethoxy-4-(2-methyl-13-dithiolan-2-yl)-N-ethyl-l-(3,4-m^ 
dioxybenzyl)-l 23,4-tetrahydroisoquinoline (9b) 
200 mg (0.45 mmol) of 9a were dissolved in 5 ml of absol. CH 2C1 2 and 
stirred under N 2 with 170 mg (0.9 mmol) of E t 3 OBF 4 in 2 ml of absol. 
CH 2C1 2 at 0° for 1 h, then for 4 h at room temp. After alkalization with 2N 
NaOH the org. layer was separated, washed with water, and dried 
(Na2S04). The resulting oil is purified by cc (Si0 2; ethyl acetate): light 
yellow oil, 175 mg (82 %). - C 2 5 H 3 1 N 0 4 S 2 (473.7). - ! H-NMR: 8 (ppm) = 
1.15 (t; J = 7.4 Hz, 3H, C H r C H ^ , 1.7 (s; 3H, CH 3), 2.37 - 3.83 (m; 12H, 
S-(CH2)2-S, Ph-CH-CH 2-N-CH-CH 2, and C l ^ - C H ^ , 3.57 (s; 3H, OCH 3), 
3.86 (s; 3H, OCH 3), 5.9 (s; 2H, 0-CH 2-0), 6.07 (s; 1H, Ar-H), 6.5 - 6.8 
(m; 3H, Ar-H), 7.47 (s; 1H, Ar-H). - MS: m/z = 471 ((M-H)+, 3 %), 352 
(3), 338 (97), 218 (100), 119(51). 
4-Acetyl-6,7-dimethoxy-l-(3,4-methylenedioxybenzy\)-l 2 3 A-
tetrahydroisoquinoline (10) 
To 7.1 g (16 mmole) dithiolane 9a, dissolved in 250 ml of CHC13 and 50 
ml of MeOH, were added 5.28 g Hg(C104)2 trihydrate in 180 ml of MeOH. 
After 1 h stirring at room temp, the precipitate was filtered off and the 
filtrate was basified by 2N Na 2 C0 3 . After evaporation of the solvents 
addition of 30 ml of 2N HCl afforded a Hg-containing crystalline precipi-
tate. The pertinent oily base 10 (5.3 g; 90 %) was liberated by 2N NaOH: 
10-HC1: m.p. 185- 187°(precipitatedfromEt20). - C 2 1 H 2 4 N 0 5 C 1 (405.9). 
Calcd. C 62.1 H 5.96 N 3.5 Found C 62.3 H 5.81 N 3.5. - UV (MeOH): X 
max (log £) = 285 (3.85), 231 nm (4.04). - IR (film): 3335 (sharp, N-H); 
1710 cm*1 (C=0). - !H-NMR: 8 (ppm) = 1.82 (s; 1H, NH), 2.15 (s; 3H, 
CH 3), 2.65 - 4.28 (m; 6H, Ph-CH-CH2-N-CH-CH2-Ph), 3.85 (s; 6H, 




3 g (8 mmole) of compound 10 were treated with 500 mg Pd/C 10 % in 8 
ml of tetraline at 180° for 40 min. After cooling and filtration the solvent 
was distilled off in vacuo, the residue was dissolved in CH 2C1 2, the solution 
was dried over Na 2 S0 4 and evaporated. The remaining oil was purified by 
cc (Si0 2, ethyl acetate): 2.7 g of a mixture of 11 and 11a which was 
separated at an analytical scale by HPLC (lichroprepsibo, 30 - 40 nm, 20 
bar, 22 ml/min; solvent: CH 2Cl2/CH 3CN 8 + 2). The CH 2C1 2 used contains 
1 % of the following mixture: 134 ml CH 2C1 2 + 31 g glacial acetic acid + 
35.4 g NEt 3. - Retention time for 11: 2.8 min, for 11a 6.2 min. 
Preparative yields: 2.4 g (82 %) 11 and 0.183 g (6.5 %) 11a. The isoqui-
noline 11 was recrystallized from diisopropylether, m.p. 165 - 166*. 11a 
was recrystallized from diisopropyl ether/CH2Cl2, m.p. 168 -169°. 
Compound 11: C 2 1 H 1 9 N 0 5 (365.4) Calcd. C 69.0 H 5.20 N 3.8 Found C 
69.1 H 5.37 N 3.6. - UV (MeOH): X. max (log e) = 335 (3.68), 322 (3.62), 
286 (3.89), 240 (sh, 3.96), 226 (sh, 4.70), 214 (4.76). - IR (KBr): 1680 cm*1 
(C=0). - ! H-NMR: 8 (ppm) = 2.75 (s; 3H, CH 3), 3.9 (s; 3H, OCH 3), 4.04 
(s; 3H, OCH3), 4.57 (s; 2H, Ph-CH2), 5.89 (s; 2H, 0-CH 2-0), 6.72 (broad 
s; 3H, Ar-H), 7.39 (s; 1H, H-5), 8.54 (s; 1H, H-8), 9.0 (s; 1H, H-3). - MS: 
m/z = 365 ( M + \ 76 %), 364 (100), 350 (40), 334 (26), 322 (11), 307 (9), 
306 (16), 135 (16). 
11a: C 2 1 H 2 1 N 0 4 (351.4) Calcd. C 71.7 H 6.02 N 3.98 Found C 72.3 H 
6.18 N 4.18 - !H-NMR: 8 (ppm) = 2.48 (s; 3H, C-3-CH3), 2.68 (s; 3H, 
C-4-CH3), 3.83 (s; 3H, OCH 3), 3.89 (s; 3H, OCH 3), 4.45 (s; 2H, Ph-CH2), 
5.83 (s; 2H, 0-CH 2-0), 6.7 (broad s; 3H, Ar-H), 7.1 (s; 1H, H-5), 7.25 (s; 
1H, H-8). - MS: m/z = 351 (M*\ 58 %), 336 (100), 320 (21), 308 (10), 305 
(9), 292 (20), 276 (11), 248 (8), 235 (7), 160 (9). 
N-[2-Acetyl-2-(3,4-dimethoxyphenyl)ethyl]-(3,4-methylenedioxyphenyl)-
acetamide (12) 
To 2.3 g (5 mmole) 7, dissolved in 100 ml of MeOH and 50 ml of Et 20, 
were added drop by drop 2.1 g (5.93 mmole) Hg(ClC>4)2 trihydrate in 50 ml 
of MeOH. The suspension was stirred for 1 h at room temp. The precipitate 
was filtered off, washed with CH 2C1 2 and discarded. The combined org. 
phases were washed with 30 ml of 2N NaOH and with saturated NaCl-sol-
ution. After drying (Na2S04) and evaporation, compound 12 was purified 
by cc (A1 20 3; OHkCtyOijN 9 + 1) and kugelrohr-distillation (200°, 0.05 
mm Hg): colourless crystals, mp. 117 - 118°, 1.8 g (93 %). - C 2 1 H 2 3 N 0 6 
(385.4) Calcd. C 65.4 H 6.01 N 3.6 Found C 65.2 H 6.18 N 3.7. - UV 
(MeOH): X max (log e) = 283 (3.81), 235 nm (4.00). - IR (KBr): 3330 
(sharp, N-H); 1720 (C=0); 1655 cm*1 (NC=0). - ^ - N M R : 8 (ppm) = 2.02 
(s; 3H, CH 3), 3.3 - 4.3 (m; 3H, Ph-CH-CH2-N), 3.39 (s; 2H, NCO-CH 2-
Ph), 3.81 (s; 3H, OCH 3), 3.84 (s; 3H, OCH 3), 5.7 - 6.03 (m; 1H, NH), 5.92 
(s; 2H, 0-CH 2-0), 6.49-6.92 (m; 6H, Ar-H). 
4-Acetyl-6,7-dimethoxy-l-(3,4-methylenedioxybenzyl)-3,4-dihydroiso-
quinoline (13) and its dehydrogenation to 11 
1.3 g (3.4 mmole) 12 were heated under reflux for 4 h with 3 ml of 
POCl 3 in 30 ml of absol. CH 3 CN under N 2 . The solvent was evaporated, 
the residue was dissolved in ice/water and basified with Na 2 C0 3 under N 2 . 
Extraction with Et 20, drying of the org. phase (Na2S04) and evaporation in 
vacuo afforded the dihydroisoquinoline 13, which was dissolved in 10 ml 
of tetraline and dehydrogenated by heating this solution to 190 - 200° with 
300 mg Pd/C 10 % for 3 h. Then the solvent was distilled off, the residue 
was suspended in CH 2C1 2 and the catalyst war removed by filtration. The 
org. phase was dried (Na2S04) and evaporated. The oily residue was puri-
fied by cc (Si0 2; ethyl acetate). - Yield (both steps): 250 mg (20 %) 11. 
4-Acetyl-6,7-dimethoxy-9-(Nfl-dimethylaminomethyl)-l-(3,4-
methylenedioxybenzyl)isoquinoline (14) 
28 mg (0.3 mmole) N,N-dimethyl-methyleneammoniumchloride and 100 
mg (0.27 mmole) 11 in 3 ml of absol. CH 3 CN were heated to 80* for 3 h. 
After evaporation of the solvent in vacuo the residue was treated with 2N 
Na2C03-solution and extracted with CH 2C1 2. Drying (Na2S04) and evap-
oration in vacuo afforded an oil which was purified by cc (Si0 2; MeOH): 
light yellow crystals, m.p. 138 - 141° (Et20/hexane), yield 90 mg (71 %). -
C 2 4 H 2 6 N 2 0 5 (422.5). - UV (MeOH): X max (log £) = 333 (3.87), 2.91 
(3.81), 251 (sh, 4.46), 2.35 nm (4.51). - IR (KBr): 1690 cm*1 (C=0). -
^ - N M R (400 MHz): 8 (ppm) = 2.35 (s; 6H, N(CH 3) 2), 2.76 (s; 3H, 
COCH 3); 3.03 - 3.08 (AA'B, dd, J 1 / 2 = 12.4/6.95 Hz, 1H, Ph-CH-CHj), 
3.64 - 3.77 (AA'B, dd, J 1 / 2 = 12.4/6.95 Hz, 1H, Ph-CH-CH^, 3.98 (s; 3H, 
OCH 3), 4.02 (s; 3H, OCH 3), 5.0 - 5.15 (m; 1H, Ph-CH-CH2), 5.85 (d, J = 
1.4 Hz, 1H, 0-CH r O), 5.88 (d; J = 1.4 Hz, 1H, 0-CH 2-0), 6.69 - 6.90 (m; 
3H, Ar-H), 7.51 (s; 1H, Ar-H), 8.50 (s; 1H, Ar-H), 9.04 (s; 1H, H-3). - MS: 
m/z = 422 (M+\ 6 %), 389 (25), 307 (100), 292 (98). 
3-Cyano-l-[6,7-dimethoxy-l-(3,4-methylenedioxybenzyl)isoquinolin-4-
yl]-propan-l-one (17) 
3.65 g (10 mmole) 11 were dissolved in 70 ml of absol. benzene under 
N 2 and stirred with 1.2 g Et 3N and 2.16 ml of F 3C-S0 2-0-Si(CH 3) 3 at 0° 
for 30 min and for 3 h at reflux temp. After cooling the benzene phase was 
separated and evaporated; viscous orange oil of 15 (4.4 g) which was not 
purified but directly dissolved in 30 ml of absol. CH 2C1 2 under N 2 at 0° and 
stirred with 2 g of N,N-dimethyl-methyleneammonium iodide first at 0° for 
1 h than for 3 h at room temp.. After evaporation of CH 2C1 2 the colourless 
oil was dissolved in 12 ml of 2N HCl at 0* under N 2 , then the solution was 
stirred for 2 h at room temp. After evaporation the Mannich base 16-HC1 
was obtained (colourless oil). - This oil and 0.7 g KCN were dissolved in 
80 ml of water of 90° and refluxed for 2 h under N 2 . After cooling extrac-
tion with CH 2C1 2, drying (Na2S04), and evaporation led to the nitrile 17 
which was purified by cc (A1203; CHC13): colourless crystals from EtOH, 
m.p. 172 - 173°, total yield (4 steps): 2.06 g (51 %). - C 2 3 H 2 0 N 2 O 5 (404.4) 
Calcd. C 68.3 H 4.98 N 6.6 Found C 68.2 H 4.98 N 6.6 - UV (MeOH): X 
max (log e) = 333 (3.88), 291 (3.81), 246 (sh, 4.47), 231 nm (4.54). - IR 
(KBr): 2260 (ON); 1675 cm"1 (C=0). - ! H-NMR: 8 (ppm) = 2.87 (t; J = 
7.5 Hz, 2H, CH2-CH2CN), 3.56 (t; J = 7.5 Hz, 2H, CH2-CH2-CN), 3.94 (s; 
3H, OCH 3), 4.08 (s; 3H, OCH 3), 4.58 (s; 2H, Ar-CH2-Ph), 5.9 (s; 2H, 
0-CH 2-0), 6.69 - 6.8 (m; 3H, Ar-H), 7.4 (s; 1H, Ar-H-5), 8.54 (s; 1H, 
Ar-H-8), 9.0 (s; 2H, Ar-H-3). - MS: m/z = 404 ( M + 80 %), 403 (100), 
389 (35), 373 (23). 
6,7-Dimethoxy-l-(3,4-methylenedioxybenzyl)-4-(1-pyrrolin-2-yl)-
isoquinoline (2b), Preininger-alkaloid 
600 mg (1.5 mmole) 17, dissolved in 100 ml of absol. EtOH, were heated 
to 40 - 45° for 5 h with 2 g Raney-Ni in 6 ml of absol. EtOH, previously 
saturated with N H 3 at 0'. Efficient cooling in order to prevent escaping of 
N H 3 is mandatory. In addition the reflux condenser has to be closed by a 
stopper plug. After cooling the catalyst was filtered off and the solvent was 
evaporated in vacuo. 2b is purified by cc (Al20 3; CHC13): colourless crys-
tals from acetone, m.p. 192- 193° (lit: 193° -195° 2 ) ) , 540 mg (92%). 
- UV (EtOH): X max (log e) = 332 (sh, 3.45), 317 (3.47), 293 (3.52), 247 
nm (4.26). - UV (EtOH + HCl): X max (log e) = 340 (3.95), 262 (4.49), 235 
nm (4.44). - IR (KBr): 1620 cm"1 (C=N). - ^ - N M R : 8 (ppm) = 2.02 - 2.10 
(m; 2H, pyrr.-H-4"), 3.12 - 3.16 (m; 2H, pyrr.-H-3"), 3.92 (s; 3H, OCH 3 
(C-7)), 4.03 (s; 3H, OCH 3 (C-6)), 4.21-4.25 (m; 2H, pyrr.-5"-H), 4.56 
(s; 2H, Ph-CH2), 5.88 (s; 2H, 0-CH 2-0), 6.7 - 6.72 (m; 2H, H-2' and H-5'), 
6.77 (dd; J G = 7 Hz, J m = 1 Hz, H-6'), 7.37 (s; 1H, H-8), 8.61 (s; 1H, H-5), 
9.02 (s; 1H, H-3). - MS: m/z = 390 (M^, 99 %), 389 (100), 375 (49), 359 
(19), 135 (24). 
6,7-Dimethoxy-9-methyl-l-(3 ,4-methylenedioxybenzyl)-4-(l -pyrrolin-
2-yl)-isoquinoline (18) 
Compound 18 is formed, if the silylated enol derivative 15 reacts for 12 h 
with N,N-dimethyl-methyleneammonium iodide. For the following steps, 
leading to nitril 17, the mixture was not separated. Compound 18 is easily 
separated from Preininger-alkaloid (2b) by cc (Si0 2; CH2CI2/CH3CN 8 + 
2) and recrystallization from EtOH: colourless crystals m.p. 142.5 - 143°, 7 
- 9 % yield. - C24H24N2O4 (404.5) Calcd. C 71.3 H 5.98 N 6.9 Found C 
71.4 H 6.11 N 6.8. - UV (EtOH): X max (log e) = 328 (sh, 3.87), 314 
(3.89), 292 (3.94), 246 nm (4.52). - IR (KBr): 1625 cm - 1 (ON). - *H-
NMR: 8 (ppm) = 1.84 (d; J = 6 Hz, 3H, Ph-CH-Ciy, 1.85 - 2.25 (m; 2H, 
pyrr.-H-4), 2.98 - 3.31 (m; 2H, pyrr.-H-3), 3.90 (s; 3H, OCH 3), 4.1 (s; 3H, 
OCH3), 4.1 - 4.37 (m; 2H, pyrr.-H-5), 4.89 (q; J = 6 Hz, 1H, Ph-CH-CH3), 
5.84 (s; 2H, 0-CH 2-0), 6.63 - 6.93 (m; 3H, Ar-H), 7.44 (s; 1H, Ar-H), 8.75 
(s; 1H, Ar-H), 9.16 (s; 1H, H-3). - MS: m/z = 404 ( M + , 100 %), 403 (86), 
389 (35), 373 (8), 149 (8), 135 (12). 
(R)-(+)-N-Formylnormacrostomine (19) 
The reducing reagent was prepared by adding 750 mg of L-Z-proline to 
35 mg of NaBH 4 in 5 ml absol. THF. This mixture was stirred for 1 h at 0° 
and 3 h at room temp.. After evaporation of THF the reducing complex is 
used as such. - 70 mg (0.18 mmole) 2b, dissolved in 4 ml of absol. CH 2C1 2, 
were added to the proline-complex mentioned above; the mixture was 
stirred for 2 h at 0" and 60 h at room temp.. After evaporation the residue 
was dissolved in 2 ml of H-CO-O-CO-CH3 at 0° and stirred for 15 min at 
0° and 15 min at room temp.. After 40 min heating at 70° excessive anhy-
dride was distilled off in vacuo. The residue was dissolved in CH 2C1 2, the 
solution was dried (Na2S04) and evaporated, the remaining oil was purified 
by cc (A1 20 3, CHCI3): colourless crystals, m.p. 140'. - IR- and mass-spec-
trum are identical with those reported for the (S)-(-)-enantiomer - Opti-
cal rotation: (+), qual. 
(R)-(+)-normacrostomine (20) 
17 mg (0.04 mmole) 19 were heated to reflux in 2.5 ml of 3N HCl for 2.5 
h. After cooling and neutralization with NaHC0 3 20 was extracted with 
CH 2C1 2. The org. phase was dried (Na2S04) and evaporated: 13 mg (84 %) 
light yellow amorphous powder. - C 2 3 H 2 4 N 2 0 4 (392.5). - UV (MeOH, 
qual.): X max = 329; 315; 284; 245 (sh); 240 nm. - IR (KBr): 3400 cm"1 
(N-H, broad). - ! H-NMR (250 MHz): 8 (ppm) = 1.85 - 4.71 (m; 8H, 
CH-(CH 2) 3-NH: pyrr.-H), 3.89 (s; 3H, OCH 3), 4.02 (s; 3H, OCH 3), 4.46 (s; 
2H, Ph-CH2), 5.86 (s; 2H, 0-CH 2-0), 6.68 - 6.76 (m; 3H, Ar-H), 7.31 (s; 
1H, Ar-H), 7.46 (s; 1H, Ar-H), 8.46 (s; 1H, Ar-H-3). - MS (12 eV): m/z = 
392 ( M + ', 100 %). - Optical rotation: (+), qual. 
(R)-(+)-macrostomine ((+)-l) 
50 mg (0.12 mmole) 19, dissolved in 4 ml of absol. THF, were added 
drop by drop under N 2 to 70 mg L i A l H 4 in 5 ml of absol. THF at 0°C. This 
mixture was stirred for 15 min at 0°, 15 min at room temp, and 40 min 
under reflux. After cooling to 0% excessive L i A l H 4 was destroyed by as 
little as possible water and the mixture was extracted with Et 2 0 (3x10 ml) 
and 10 ml of CH 2C1 2. The combined org. phases were dried (Na2S04) and 
evaporated. (+)-l was purified by cc (A1 20 3; CH 2C1 2/CH 3CN 9+1): light 
yellow powder, 44 mg (90 %). - m.p. 95 - 100'C (lit. 2 ) : 107 - 110° for 
optically pure (-)-l). - [a)g = 37° (c = 0.9, C H C 1 3 ; lit. 2 ) : 51e): optical 
purity = 72 %. - ! H-NMR (400 MHz): 8 (ppm) = 1.9 - 2.08 (m; 3H, H-3", 
H-4", H-5"), 2.25 (s; 3H, N-CH 3), 2.29 - 2.37 (m; 2H, H-3", H-4"), 3.28 
- 3.33 (m; 1H, H-5"), 3.5 - 3.56 (m; 1H, H-2"), 3.89 (s; 3H, OCH 3), 3.99 
(s; 3H, OCH3), 4.49 (s; 2H, Ph-CH2), 5.87 (s; 2H, 0-CH 2-0), 6.7 - 6.72 
(m; 1H, H-6*), 6.77 - 6.79 (m; 2H, H-2' and H-5'), 7.32 (s; 1H, H-8), 7.79 
(s; 1H, H-5), 8.40 (s; lH,H-3). 
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